u/kkgy00

A network meta-analysis just published in Phytomedicine compared Bacopa monnieri and Ginkgo biloba for cognitive performance in healthy adults.

Key findings:

• High-dose Bacopa (≥600mg/day) significantly outperformed Ginkgo AND placebo for working memory and short-term memory.
• Lower doses (300mg) still performed better than Ginkgo for delayed memory, but the real gains showed up at 600mg+
• Brahmi and Ginkgo did not differ in their effects on attention or processing speed.

Analyses of this recent study revealed significant favourable effects of saffron compared to placebo across multiple health indices. Specifically, saffron supplementation led to significant reductions in CRP values, distress, anxiety, depression, fatigue, and the Parkinson's Disease Summary Index (PDSI). It also significantly improved cognitive status, sleep quality, and various aspects of quality of life, including mobility, daily activity, cognitive impairment, and bodily discomfort. A marginal, though not statistically significant, decrease in malondialdehyde (MDA) was also observed in the saffron group. The findings conclude that 100 mg daily saffron supplementation for 12 weeks may be effective in managing PD symptoms and improving patient well-being.

Analyses of this recent study revealed significant favourable effects of saffron compared to placebo across multiple health indices. Specifically, saffron supplementation led to significant reductions in CRP values, distress, anxiety, depression, fatigue, and the Parkinson's Disease Summary Index (PDSI). It also significantly improved cognitive status, sleep quality, and various aspects of quality of life, including mobility, daily activity, cognitive impairment, and bodily discomfort. A marginal, though not statistically significant, decrease in malondialdehyde (MDA) was also observed in the saffron group. The findings conclude that 100 mg daily saffron supplementation for 12 weeks may be effective in managing PD symptoms and improving patient well-being.